The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.

Herpes is one of the most common viral infections in the world, yet it remains widely misunderstood. Caused by the herpes ...

The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.

A phase 3 trial finds pritelivir significantly improves cure rates for immunocompromised individuals with refractory HSV infections.

Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...

Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care ...

Researchers at the University of Jyväskylä (Finland), in cooperation with national and international research groups, have ...

Add Yahoo as a preferred source to see more of our stories on Google. man holding a hand ove rhis mouth A new study has confirmed genital herpes is the most common sexually transmitted infection (STI) ...

Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally – according to new estimates released today. At least 1 person ...

People diagnosed with HSV-1 infection had a higher risk of a subsequent Alzheimer's diagnosis. Antiherpetic drugs reduced Alzheimer's risk in those diagnosed with HSV-1. The findings apply only to ...